OP006 Personalized thiopurine dosing based on TPMT genotyping reduces leucopenia occurrence and results in cost-savings in IBD patients. Results from a randomized trial in the Netherlands

Verfasser: Coenen, M.
van Marrewijk, C.
Derijks, L.
Vermeulen, S.
Wong, D.
Klungel, O.
Verbeek, A.
Hooymans, P.
Scheffer, H.
Guchelaar, H.-J.
Franke, B.
de Jong, D.
Dokumenttyp: Artikel
Erscheinungsdatum: 2014
Reihe/Periodikum: Journal of Crohn's and Colitis ; volume 8, page S4 ; ISSN 1873-9946
Verlag/Hrsg.: Oxford University Press (OUP)
Schlagwörter: Gastroenterology / General Medicine
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27223332
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1016/s1873-9946(14)60007-6